Case report reveals hemophagocytosis in acute monoblastic leukemia, indicating poor prognosis due to chromosomal abnormalities.
Hemophagocytosis is a rare feature in leukemic blasts, occurring in approximately 1% of acute myeloid leukemias (AML), mainly in the monoblastic or monocytic subtypes [1,2]. Associations with chromosomal abnormalities, particularly t(8;16), have been reported, and the presence of hemophagocytic blasts can help suggest such cytogenetic alterations [2]. Unlike macrophage activation syndrome (MAS), no specific treatment is usually indicated for patients presenting hemophagocytic blasts [3]. We report a rare case of hemophagocytosis occurring in acute monoblastic leukemia with a complex karyotype associated with a poor prognosis according to the European LeukemiaNet (ELN) 2022 risk classification [4]. The clinical course was complicated by disseminated intravascular coagulation (DIC), and the patient died on the fourth day of induction therapy, emphasizing the adverse nature of this entity.
No takes yet. Share an insight, caveat, or question.
Khadija et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: